Dexelvucitabine
id:
dexelvucitabine-318-18184204
title:
Dexelvucitabine
text:
Dexelvucitabine is a failed experimental agent for the management of human immunodeficiency virus infection. It is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. that inhibits HIV-1 replication in vitro. During phase II clinical trials there was some indication of a decreased mean viral load in patients with infected human immunodeficiency virus. On April 3, 2006, Pharmasset and Incyte, the pharmaceutical companies developing dexelvucitabine, announced the decision
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dexelvucitabine
date created:
date modified:
2023-04-30T19:03:01Z
main entity:
{"identifier":"Q5268320","url":"https://www.wikidata.org/entity/Q5268320"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/62/Dexelvucitabine.svg","width":512,"height":454}
fields total:
13
integrity:
15